Regulations.gov document
Attachment 3 - "Questions and Answers: Delayed-Release Pancreatic Enzyme Product Receives…
Supporting & Related Material · FDA-2010-P-0614 · posted Jun 21, 2011
Key facts
| Document ID | FDA-2010-P-0614-0081 |
|---|---|
| Title | Attachment 3 - "Questions and Answers: Delayed-Release Pancreatic Enzyme Product Receives FDA Approval" - [Mutual Pharmaceutical Company, Inc. (Sidley Austin LLP) - Reply Comment] |
| Document type | Supporting & Related Material |
| Subtype | Reply Comment (RC) |
| Agency | FDA |
| Docket | FDA-2010-P-0614 |
| Posted | Jun 21, 2011 |
| Effective date | May 16, 2011 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: